Sec. 10328. IMPROVEMENT IN PART D MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMS

523 words·~2 min read·/statute-compilations/comps-9307/sec-10328

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 10328 IMPROVEMENT IN PART D MEDICATION THERAPY MANAGEMENT

(MTM)PROGRAMS ###

(a)In General Section 1860D–4(c)(2) of the Social Security Act (42 U.S.C. 1395w–104(c)(2)) is amended— ####

(1)by redesignating subparagraphs (C), (D), and

(E)as subparagraphs (E), (F), and (G), respectively; and ####

(2)by inserting after subparagraph

(B)the following new subparagraphs: > > ##### “(C) Required interventions > > For plan years beginning on or after the date that is 2 years after the date of the enactment of the Patient Protection and Affordable Care Act, prescription drug plan sponsors shall offer medication therapy management services to targeted beneficiaries described in subparagraph (A)(ii) that include, at a minimum, the following to increase adherence to prescription medications or other goals deemed necessary by the Secretary: > > > ###### “(i) > > An annual comprehensive medication review furnished person-to-person or using telehealth technologies (as defined by the Secretary) by a licensed pharmacist or other qualified provider. The comprehensive medication review— > > > ###### “(I) > > shall include a review of the individual's medications and may result in the creation of a recommended medication action plan or other actions in consultation with the individual and with input from the prescriber to the extent necessary and practicable; and > > > ###### “(II) > > shall include providing the individual with a written or printed summary of the results of the review. > > The Secretary, in consultation with relevant stakeholders, shall develop a standardized format for the action plan under subclause

(I)and the summary under subclause (II). > > > ###### “(ii) > > Follow-up interventions as warranted based on the findings of the annual medication review or the targeted medication enrollment and which may be provided person-to-person or using telehealth technologies (as defined by the Secretary). > > > ##### “(D) Assessment > > The prescription drug plan sponsor shall have in place a process to assess, at least on a quarterly basis, the medication use of individuals who are at risk but not enrolled in the medication therapy management program, including individuals who have experienced a transition in care, if the prescription drug plan sponsor has access to that information. > > > ##### “(E) Automatic enrollment with ability to opt-out > > The prescription drug plan sponsor shall have in place a process to— > > > ###### “(i) > > subject to clause (ii), automatically enroll targeted beneficiaries described in subparagraph (A)(ii), including beneficiaries identified under subparagraph (D), in the medication therapy management program required under this subsection; and > > > ###### “(ii) > > permit such beneficiaries to opt-out of enrollment in such program.” > . ###

(b)Rule of Construction **[**[42 U.S.C. 1395w–104 note](/us/usc/t42/s1395w–104)**]** Nothing in this section shall limit the authority of the Secretary of Health and Human Services to modify or broaden requirements for a medication therapy management program under part D of title XVIII of the Social Security Act or to study new models for medication therapy management through the Center for Medicare and Medicaid Innovation under section 1115A of such Act, as added by section 3021.

Connections2 off-index

2 references not yet in our index

42 USC 1395w–104(c)(2)
42 USC 1395w–104

Citation graph

cites case law

Sec. 10328

IMPROVEMENT IN PART D MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMS

Cite42 USC 1395w–104(c)(2)

Cite42 USC 1395w–104

Cites 2Cited by 0 across 0 sources